Avid Bioservices Inc. (CDMO)

Name: Avid Bioservices Inc. (CDMO) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Avid Bioservices Inc. (CDMO)

Stock Card

$12.49

$0.00 (0.00%)

As on 06-Feb-2025 09:30EDT

Market cap

$799 Mln

Revenue (TTM)

$150 Mln

P/E Ratio

P/B Ratio

17.8

Div. Yield

0 %

Avid Bioservices (CDMO) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 12.49 High: 12.49

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.2 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

107.9
Debt to Equity

3.4
Book Value

$--
EPS

$--
Face value

--
Shares outstanding

63,963,300

10 Years Aggregate

CFO

$-148.42 Mln

EBITDA

$-166.01 Mln

Net Profit

$-63.37 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Avid Bioservices (CDMO)	1.1	1.3	18.5	99.2	-13.6	13.9	7.0
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 06-Feb-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020	2019	2018
Avid Bioservices (CDMO)	89.0	-52.8	-52.8	152.9	50.5	87.1	39.8
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	4.4	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Avid Bioservices (CDMO)

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and... commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California. Read more

President, CEO & Director

Mr. Nicholas Stewart Green B.Sc., MBA
President, CEO & Director

Mr. Nicholas Stewart Green B.Sc., MBA
Headquarters

Tustin, CA
Website

https://www.avidbio.com

FAQs for Avid Bioservices (CDMO)

What is the current share price of Avid Bioservices Inc (CDMO) Today?

The share price of Avid Bioservices Inc (CDMO) is $12.49 (NASDAQ) as of 06-Feb-2025 09:30 EDT. Avid Bioservices Inc (CDMO) has given a return of -13.61% in the last 3 years.

What is the current PB & PE ratio of Avid Bioservices Inc (CDMO)?

Since, TTM earnings of Avid Bioservices Inc (CDMO) is negative, P/E ratio is not available.
The P/B ratio of Avid Bioservices Inc (CDMO) is 17.83 times as on 06-Feb-2025, a 130 premium to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	--	--
2023	--	--
2022	--	--
2021	--	--
2020	--	--

What is the 52 Week High and Low of Avid Bioservices Inc (CDMO)?

The 52-week high and low of Avid Bioservices Inc (CDMO) are Rs -- and Rs -- as of 30-Aug-2026.

What is the market cap of Avid Bioservices Inc (CDMO)?

Avid Bioservices Inc (CDMO) has a market capitalisation of $ 799 Mln as on 06-Feb-2025. As per SEBI classification, it is a Small Cap company.

Should I invest in Avid Bioservices Inc (CDMO)?

Before investing in Avid Bioservices Inc (CDMO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.